{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:09:21Z","timestamp":1762430961805},"reference-count":101,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,2]],"date-time":"2015-03-02T00:00:00Z","timestamp":1425254400000},"content-version":"vor","delay-in-days":152,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.rgmx.2014.09.004","type":"journal-article","created":{"date-parts":[[2014,12,6]],"date-time":"2014-12-06T18:05:26Z","timestamp":1417889126000},"page":"250-262","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Consenso mexicano de diagn\u00f3stico y manejo del carcinoma hepatocelular"],"prefix":"10.1016","volume":"79","author":[{"given":"Mar\u00eda Sarai","family":"Gonz\u00e1lez Huezo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Francisco","family":"S\u00e1nchez \u00c1vila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 3","key":"10.1016\/j.rgmx.2014.09.004_bib0005","doi-asserted-by":"crossref","first-page":"s206","DOI":"10.1016\/S1590-8658(10)60507-5","article-title":"The changing pattern of epidemiology in hepatocellular carcinoma","volume":"42","author":"Nordenstedt","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0030-1247128","article-title":"Hepatocellular carcinoma: Epidemiology, surveillance and diagnosis","volume":"30","author":"Sherman","year":"2010","journal-title":"Semin Liv Dis"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0015","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1001\/archinte.167.18.1983","article-title":"Epidemiology of hepatocellular carcinoma in Hispanics in the United States","volume":"167","author":"El-Serag","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0020","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1200\/JCO.2008.20.7753","article-title":"Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005","volume":"27","author":"Alterkruse","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0025","first-page":"1401","article-title":"Hepatocellular carcinoma and hepatic cirrhosis in Mexico: 25 year necropsy review","volume":"44","author":"Cort\u00e9s-Espinosa","year":"1997","journal-title":"HepatoGastroenterology"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0030","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1665-2681(19)31852-6","article-title":"Mortality trends for liver cancer in Mexico from 2000 to 2006","volume":"7","author":"M\u00e9ndez-S\u00e1nchez","year":"2008","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0615","first-page":"34","article-title":"Carcinoma hepatocelular. Experiencia del Instituto Nacional de Cancerolog\u00eda","volume":"62","author":"Mondrag\u00f3n-S\u00e1nchez","year":"1997","journal-title":"Rev Gastroenterol Mex"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0620","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1665-2681(19)31768-5","article-title":"Hepatocellular carcinoma: Epidemiological profile from a cohort of federal employees in Mexico","volume":"8","author":"Ladr\u00f3n de Guevara","year":"2009","journal-title":"Ann Hepatol"},{"issue":"Suppl 2","key":"10.1016\/j.rgmx.2014.09.004_bib0625","first-page":"70","article-title":"Comportamiento epidemiol\u00f3gico y factores de riesgo del carcinoma hepatocelular en Veracruz","volume":"76","author":"Romero Sierra","year":"2011","journal-title":"Rev Gastroenterol Mex"},{"issue":"Suppl 2","key":"10.1016\/j.rgmx.2014.09.004_bib0630","first-page":"111","article-title":"Caracterizaci\u00f3n, estadificaci\u00f3n y tratamiento de pacientes con hepatocarcinoma, experiencia de 22 meses en el Instituto de Seguridad Social del Estado de M\u00e9xico y Municipios (ISSEMYM)","volume":"76","author":"Chevreuil Ben\u00edtez","year":"2011","journal-title":"Rev Gastroenterol Mex"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0635","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1016\/S1665-2681(19)32122-2","article-title":"Etiology of liver cirrosis in Mexico","volume":"3","author":"M\u00e9ndez-S\u00e1nchez","year":"2004","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0640","first-page":"133","article-title":"Carcinoma primario del h\u00edgado, estudio anatomolcl\u00ednico de 109 casos","volume":"34","author":"Ramos-Mart\u00ednez","year":"1982","journal-title":"Rev Invest Clin"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0065","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMoa0707615","article-title":"Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon","volume":"359","author":"Di Bisceglie","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0070","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1756283X10385964","article-title":"Surveillance for hepatocellular carcinoma: in whom and how?","volume":"4","author":"El-Serag","year":"2011","journal-title":"Ther Adv Gastroenterol"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0075","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/hep.23615","article-title":"Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States","volume":"52","author":"Davila","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0080","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: An update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0085","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL\u2013EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma","volume":"56","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0505","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s12072-010-9165-7","article-title":"Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma","volume":"4","author":"Masao Omata","year":"2010","journal-title":"Hepatol Int"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0095","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cld.2004.12.006","article-title":"Screening test for hepatocellular carcinoma","volume":"9","author":"Marrero","year":"2005","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0100","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1055\/s-2006-951606","article-title":"Serum markers of hepatocellular carcinoma","volume":"26","author":"Spangenberg","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2036.2009.04014.x","article-title":"Metaanalysis: Surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis","volume":"30","author":"Singal","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0510","doi-asserted-by":"crossref","first-page":"6744","DOI":"10.3748\/wjg.v19.i40.6744","article-title":"Karel J van Erpecum Surveillance for hepatocellular carcinoma in chronic liver disease: Evidence and controversies","volume":"19","author":"Suzanne van Meer","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0115","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1053\/bega.1999.0052","article-title":"Screening for hepatocellular carcinoma","volume":"13","author":"Sherman","year":"1999","journal-title":"Baillieres Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0120","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jhep.2010.03.010","article-title":"Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival","volume":"53","author":"Santi","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0125","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S1665-2681(19)32093-9","article-title":"In whom, how and how often is surveillance for hepatocellular carcinoma cost-effective?","volume":"3","author":"Ruelas-Villavicencio","year":"2004","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0130","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0168-8278(00)00053-2","article-title":"Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: Influence of HBsAg and anti-HCV status","volume":"34","author":"Trevisani","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0135","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jhep.2005.03.019","article-title":"Serum alpha-fetoprotein levels in patients with advanced hepatitis C: Results from the HALT-C Trial","volume":"43","author":"Di Bisceglie","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0140","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1111\/j.1572-0241.2007.01395.x","article-title":"Surveillance for early diagnosis of hepatocellular carcinoma: Is it effective in intermediate\/advanced cirrhosis?","volume":"102","author":"Trevisani","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0145","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/hep.21966","article-title":"Diagnosis of hepatic nodules 20mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma","volume":"47","author":"Forner","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0150","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/gut.2009.187286","article-title":"The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis","volume":"59","author":"Sangiovanni","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0155","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/hep.22709","article-title":"Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia","volume":"49","author":"International Consensus Group for Hepatocellular Neoplasia","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0160","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/hep.21531","article-title":"Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis","volume":"45","author":"Di Tommaso","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0165","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: The BCLC staging classification","volume":"19","author":"Llovet","year":"1999","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0515","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.20636","article-title":"Prognosis of hepatocellular carcinoma: Comparison of 7 staging systems in an American Cohort","volume":"41","author":"Jorge Marrero","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0520","first-page":"348","article-title":"Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: Proposal for a subclassification to facilitate treatment decisions","volume":"32","author":"Luigi Bolondi","year":"2012","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0180","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0185","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.amjsurg.2005.01.043","article-title":"How much liver resection is too much","volume":"190","author":"Mullin","year":"2005","journal-title":"Am J Surg"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0525","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1055\/s-0033-1351777","article-title":"Gebhard Wagener Assessment of hepatic function, operative candidacy and medical management after liver resection in the patient with underlying liver disease","volume":"33","year":"2013","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0195","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00000658-199903000-00004","article-title":"Hepatectomy for hepatocellular carcinoma: Toward zero hospital deaths","volume":"229","author":"Fan","year":"1999","journal-title":"Ann Surg"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0200","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/SLA.0b013e31815f6e5b","article-title":"Preoperative portal vein embolization form major liver resection: A meta-analysis","volume":"247","author":"Abulkhir","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0205","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jso.21928","article-title":"Preoperative portal vein embolization (PVE) form patients with hepatocellular carcinoma can improve resectability and may improve disease-free survival","volume":"104","author":"Okabe","year":"2011","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0530","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1056\/NEJMra065156","article-title":"Strategies for Liver Surgery and Partial Liver Transplantation","volume":"15","author":"Clavien","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0215","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.gassur.2003.09.012","article-title":"Impact of steatosis on perioperative outcome following hepatic resection","volume":"7","author":"Kooby Da Fong","year":"2003","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0535","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1055\/s-0033-1351782","article-title":"Chung Mau Lo. Resection strategies for hepatocellular carcinoma","volume":"33","year":"2013","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0540","doi-asserted-by":"crossref","first-page":"6398","DOI":"10.3748\/wjg.v18.i44.6398","article-title":"Current concepts in hepatic resection for hepatocellular carcinoma in cirrhotic patients","volume":"8","author":"Cucchetti","year":"2012","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.rgmx.2014.09.004_bib0230","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/01.RVI.0000159543.28222.73","article-title":"Portal vein embolization in preparation for major hepatic resection: Evolution of a new standard of care","volume":"16","author":"Madoff","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0545","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.3748\/wjg.v18.i19.2371","article-title":"Comparison of percutaneous transhepatic portal vein embolization and unilateral portal vein ligation","volume":"18","author":"Lida","year":"2012","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.rgmx.2014.09.004_bib0240","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-0033-1351778","article-title":"Interventional radiology in the multidisciplinary management of liver lesions: Pre- and postoperative roles","volume":"33","author":"Ward","year":"2013","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0245","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1245\/s10434-006-9318-z","article-title":"Anatomic resection independently improves long-term survival in patients with T1-T2 hepatocellular carcinoma","volume":"14","author":"Wakai","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0550","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1245\/s10434-012-2450-z","article-title":"A comprehensive meta-regression analysis on outcome of anatomic versus non anatomic resection for hepatocellular carcinoma","volume":"19","author":"Cucchetti","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0255","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00534-004-0965-9","article-title":"Assessment of hepatic reserve for indication of hepatic resection: Decision tree incorporating indocyanine Green test","volume":"12","author":"Imamura","year":"2005","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0260","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.3748\/wjg.v17.i46.5083","article-title":"Hepatocellular carcinoma in cirrhotic patients with portal hypertension: Is liver resection always contraindicated?","volume":"14","author":"Ruzzenente","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0265","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-2005-871198","article-title":"Resection and liver transplantation for hepatocellular carcinoma","volume":"25","author":"Llovet","year":"2005","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0270","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3748\/wjg.14.685","article-title":"Makuuchi criteria for resection on the cirrhotic liver","volume":"14","author":"Yamazaki","year":"2008","journal-title":"World J Gastro"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0275","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s13304-011-0069-4","article-title":"Surgical treatment of HCC: Update topics","volume":"63","author":"Makuuchi","year":"2011","journal-title":"Updates Surg"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0280","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/SLA.0b013e3182111195","article-title":"Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: A 20 years experience","volume":"253","author":"Fan","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0285","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/hep.25832","article-title":"Resection for hepatocellular carcinoma<=2cm: Results from two western centers","volume":"57","author":"Roayaie","year":"2013","journal-title":"Hepatology"},{"issue":"Suppl 2","key":"10.1016\/j.rgmx.2014.09.004_bib0555","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1002\/lt.22365","article-title":"Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience","volume":"17","author":"Mazzaferro","year":"2011","journal-title":"Liver Transpl."},{"key":"10.1016\/j.rgmx.2014.09.004_bib0295","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1111\/j.1600-6143.2007.01965.x","article-title":"Liver transplantation for hepatocellular carcinoma: Validation of the UCSF-expanded criteria based on preoperative imaging","volume":"7","author":"Yao","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0560","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S1470-2045(11)70175-9","article-title":"Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report","volume":"13","author":"Pierre-Alain Clavien","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0305","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1002\/lt.20263","article-title":"Selection of candidates with HCC for transplantation in the MELD era","volume":"10","author":"Sala","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0310","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000342813","article-title":"Multimodality treatment for early-stage hepatocellular carcinoma: a bridging therapy for liver transplantation","volume":"86","author":"Ashoori","year":"2012","journal-title":"Digestion"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0315","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/hep.22412","article-title":"Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: An intention-to-treat analysis","volume":"48","author":"Yao","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0320","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/00000658-200204000-00012","article-title":"Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters","volume":"235","author":"Roayaie","year":"2002","journal-title":"Ann Surg"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0325","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1111\/j.1600-6143.2008.02351.x","article-title":"Liver transplantation for hepatocellular carcinoma: Beyond the Milan criteria","volume":"8","author":"Yao","year":"2008","journal-title":"Am J Transpl"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0330","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/01.sla.0000098621.74851.65","article-title":"Resection prior to liver transplantation for hepatocellular carcinoma","volume":"238","author":"Belghiti","year":"2003","journal-title":"Ann Surg"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0335","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/bjs.5528","article-title":"Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma","volume":"94","author":"Lo","year":"2007","journal-title":"Br J Surg."},{"key":"10.1016\/j.rgmx.2014.09.004_bib0565","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/archsurg.140.4.353","article-title":"Twenty-year experience with liver transplantation for hepatocellular carcinoma","volume":"140","author":"Island","year":"2005","journal-title":"Arch Surg"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0345","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1245\/s10434-012-2655-1","article-title":"Single HCC in cirrhotic patients: Liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis","volume":"20","author":"Sapisochin","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0350","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1432-2277.2007.00597.x","article-title":"Superiority of transplantation versus resection for the treatment of small hepatocellular carcinoma","volume":"21","author":"Baccarani","year":"2008","journal-title":"Transpl Int"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0355","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.23725","article-title":"Loco-regional treatment of hepatocellular carcinoma","volume":"52","author":"Lencioni","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0570","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-2005-871199","article-title":"Nathalie Ganne, and Jean-Claude Trinchet Local\/Regional and Systemic Treatments of Hepatocellular Carcinoma","volume":"25","author":"Michel Beaugrand","year":"2005","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0365","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1148\/radiology.197.1.7568806","article-title":"Hepatocellular carcinoma and cirrhosis in 746 patients: Long-term results of percutaneous ethanol injection","volume":"197","author":"Livraghi","year":"1995","journal-title":"Radiology"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0370","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0168-8278(00)80072-0","article-title":"Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection","volume":"32","author":"Khan","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0375","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1053\/j.gastro.2005.04.009","article-title":"A randomized controlled trial of radiofrequency ablation versus ethanol injection for small hepatocellular carcinoma","volume":"129","author":"Shiina","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0380","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1148\/radiol.2281020718","article-title":"Small hepatocellular carcinoma in cirrhosis: Randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection","volume":"228","author":"Lencioni","year":"2003","journal-title":"Radiology"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0575","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/ajg.2008.80","article-title":"Radiofrequency Thermal Ablation vs. Percutaneous Ethanol Injection for Small Hepatocellular Carcinoma in Cirrhosis: Meta-Analysis of Randomized Controlled Trials","volume":"104","author":"Ambrogio Orlando","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0390","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/hep.22648","article-title":"Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies","volume":"49","author":"Cho","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0395","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-230X-9-31","article-title":"Meta-analysis of percutaneous radiofrequency ablation vs ethanol injection in hepatocellular carcinoma","volume":"9","author":"Bouza","year":"2009","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0400","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jhep.2009.12.004","article-title":"Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocellular carcinoma: A meta-analysis","volume":"52","author":"Germani","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0405","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1053\/j.gastro.2004.09.030","article-title":"Treatment of hepatocellular carcinoma by percutaneous ablation methods: Ethanol injection therapy and radiofrequency ablation","volume":"127","author":"Omata","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0410","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1148\/radiol.2343040350","article-title":"Early-stage hepatocellular carcinoma in cirrhosis: Long term results of percutaneous image-guided radiofrequency ablation","volume":"234","author":"Lencioni","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0415","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/S0168-8278(12)60009-9","article-title":"Management of HCC","volume":"56","author":"Rodriguez de Lope","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0420","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jhep.2005.06.001","article-title":"Percutaneous ethanol injection in hepatocellular carcinoma: Alive or dead","volume":"43","author":"Lencioni","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0580","doi-asserted-by":"crossref","unstructured":"Douglas E Ramsey, Lily Y Kernagis, Michael C. Soulenand Jean-Francois Geschwind. Chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol 2002, 13:s211-s221","DOI":"10.1016\/S1051-0443(07)61789-8"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0585","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/jhep.2003.50047","article-title":"Llovet and Jordi Bruix Systematic Review of Randomized Trials for Unresectable Hepatocellular Carcinoma: Chemoembolization Improves Survival","volume":"37","author":"Josep","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0435","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.jhep.2012.07.025","article-title":"Response rate and clinical outcome of HCC after first and repeated cTACE performed on demand","volume":"57","author":"Terzi","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0590","article-title":"Radioembolization for Hepatocellular carcinoma with portal Vein Thrombosis: Impact of Liver function on Systemic Treatment Options at disease Progression","author":"Memon","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0595","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jhep.2011.07.012","article-title":"Jose Bilbao Radioembolization for hepatocellular carcinoma","volume":"56","author":"Bruno Sangro","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0600","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.jhep.2012.01.008","article-title":"Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolization (TACE) using Drug Eluting Beads, implications for clinical practice and trial design","volume":"56","author":"Burrel","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0455","first-page":"24","article-title":"Safety and efficacy of oxorubicin drug-eluting bead transarterial vhemoembolization in patients with advanced hepatocarcinoma","author":"Prajapati","year":"2013","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0460","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0605","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.hepres.2004.02.009","article-title":"Over-expression of c-raf-1 proto-oncogene in liver cirrhosis and hepatocellular carcinoma","volume":"29","author":"Hwang","year":"2004","journal-title":"Hepatol Res"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0470","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1200\/JCO.2005.01.3441","article-title":"Phase II study of sorafenib in patients with advanced hepatocellular carcinoma","volume":"24","author":"Abou-Alfa","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0475","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev.med.080608.100623","article-title":"Hepatocellular carcinoma: Novel molecular approaches for diagnosis, prognosis, and therapy","volume":"61","author":"Villanueva","year":"2010","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0480","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.bcp.2010.03.034","article-title":"Molecularly targeted therapy in hepatocellular carcinoma","volume":"80","author":"Huynh","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0610","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/cld.128","article-title":"Roniel Cabrera Systemic targeted therapy beyond sorafenib","volume":"1","year":"2012","journal-title":"Clinical Liver Disease"},{"issue":"Suppl 1","key":"10.1016\/j.rgmx.2014.09.004_bib0490","first-page":"s11","article-title":"Emerging targeted strategies in advanced hepatocellular carcinoma","volume":"33","author":"Finn","year":"2013","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0495","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/j.1365-2036.2006.02932.x","article-title":"Up-dated systematic review of randomized controlled trials in hepatocellular carcinoma","volume":"23","author":"Lopez","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0500","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/jnci\/dji315","article-title":"A randomized phase III study of doxorubicin versus cisplatin\/interferon alpha -2b\/doxorubicin\/fluorouracil (PIAF) combination therapy for unresectable hepatocellular carcinoma","volume":"97","author":"Yeo","year":"2005","journal-title":"J Nat Cancer Inst"},{"key":"10.1016\/j.rgmx.2014.09.004_bib0645","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"}],"container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037509061400086X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037509061400086X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T02:06:24Z","timestamp":1566093984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037509061400086X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":101,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S037509061400086X"],"URL":"https:\/\/doi.org\/10.1016\/j.rgmx.2014.09.004","relation":{},"ISSN":["0375-0906"],"issn-type":[{"value":"0375-0906","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consenso mexicano de diagn\u00f3stico y manejo del carcinoma hepatocelular","name":"articletitle","label":"Article Title"},{"value":"Revista de Gastroenterolog\u00eda de M\u00e9xico","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmx.2014.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Asociaci\u00f3n Mexicana de Gastroenterolog\u00eda. Published by Masson Doyma M\u00e9xico S.A.","name":"copyright","label":"Copyright"}]}}